Client issue
A mid-sized, immunology-focused biopharmaceutical company with a new-to-market, 3rd-generation biologic engaged CRA’s Life Sciences Practice to drive excellence in data integration initiatives and provide critical business-oriented analytics methodology leadership, most notably for patient-level claims analysis.
CRA approach
Leveraging business-context knowledge and analytics expertise, a CRA team partnered with the client on analysis platform initiatives to ensure quality backend processing rules and effective downstream deliverables for use in the home office and field sales reporting.
Client impact
The client successfully leveraged the advisory services and methodology developed by the CRA team to ensure the timely deployment of their new data and analytics platform, supporting both product and new indication launches and maximizing their return on investment.
